Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Current Taxes (2018 - 2023)

BioNexus Gene Lab's Current Taxes history spans 6 years, with the latest figure at $2177.0 for Q3 2023.

  • For Q3 2023, Current Taxes changed N/A year-over-year to $2177.0; the TTM value through Sep 2023 reached $2177.0, changed N/A, while the annual FY2021 figure was $97585.0, 59.16% up from the prior year.
  • Current Taxes for Q3 2023 was $2177.0 at BioNexus Gene Lab, down from $40104.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $148199.0 in Q3 2021 and bottomed at $174.0 in Q2 2020.
  • The 5-year median for Current Taxes is $34338.0 (2019), against an average of $48987.1.
  • The largest annual shift saw Current Taxes crashed 99.49% in 2020 before it soared 60912.07% in 2021.
  • A 5-year view of Current Taxes shows it stood at $33983.0 in 2019, then surged by 80.42% to $61313.0 in 2020, then surged by 59.16% to $97585.0 in 2021, then plummeted by 58.9% to $40104.0 in 2022, then tumbled by 94.57% to $2177.0 in 2023.
  • Per Business Quant, the three most recent readings for BGLC's Current Taxes are $2177.0 (Q3 2023), $40104.0 (Q2 2022), and $71705.0 (Q1 2022).